Evidence method
Level · gp.fundamentals.capex_revenue_ratio
8.45% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
ORGO · Mar 31, 2026
Organogenesis Holdings Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001661181-26-000008General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
56.75% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-57.06% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
76.35% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-185.05% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
40.72% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
9.77% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History11 statesHistory building
Dec 31, 20230/8 normalizedLevel 3Mar 31, 20240/8 normalizedLevel 3Jun 30, 20240/8 normalizedLevel 3Sep 30, 20240/8 normalizedLevel 3Dec 31, 20240/8 normalizedLevel 3Mar 31, 20250/8 normalizedLevel 3Jun 30, 20250/7 normalizedLevel 3Sep 30, 20250/7 normalizedLevel 3Dec 31, 20256/7 normalizedLevel 3Mar 31, 20266/7 normalizedLevel 3Jun 30, 20266/7 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 2.51%
- Current
- 8.45%
- Delta
- 5.94%
- Previous
- -1.83%
- Current
- 56.75%
- Delta
- 58.58%
- Previous
- 17.04%
- Current
- -57.06%
- Delta
- -74.09%
- Previous
- 5.25%
- Current
- 76.35%
- Delta
- 71.10%
- Previous
- 7.92%
- Current
- -185.05%
- Delta
- -192.97%
- Previous
- 7.90%
- Current
- 40.72%
- Delta
- 32.83%
- Previous
- 2.36%
- Current
- 9.77%
- Delta
- 7.41%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Has State · Organogenesis Holdings Inc. →Transitioned To · ORGO Fundamental State →Transitioned To · ORGO CAPEX_INTENSITY_INCREASED →Transitioned To · ORGO CASH_GENERATION_INCREASED →Transitioned To · ORGO GROWTH_DECREASED →Transitioned To · ORGO INVENTORY_PRESSURE_INCREASED →Transitioned To · ORGO PROFITABILITY_DECREASED →Transitioned To · ORGO R_AND_D_INTENSITY_INCREASED →Transitioned To · ORGO SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.